Drug Trial Radar · NCT06586671
A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007)
Last checked: Nov 20, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Aug 28, 2023
Primary completion
Nov 13, 2023
Study completion Nov 13, 2023
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of the study is to measure and compare the levels of nemtabrutinib in the blood after taking different forms of nemtabrutinib orally on an empty stomach (fasted) to see if they are the same or different.
Conditions
- Hematological Malignancy
Interventions
NemtabrutinibDrug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Parts 1 and 2: Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of NemtabrutinibTime frame: At designated time points (up to approximately 2 weeks)
- Parts 1 and 2: Maximum Plasma Concentration (Cmax) of NemtabrutinibTime frame: At designated time points (up to approximately 2 weeks)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
QPS-MRA, LLC-Early Phase (Site 0002)
South Miami, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.